141 related articles for article (PubMed ID: 36802449)
1. Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site.
Tan L; Wu C; Zhang J; Yu Q; Wang X; Zhang L; Ge M; Wang Z; Ouyang L; Wang Y
J Med Chem; 2023 Mar; 66(5):3588-3620. PubMed ID: 36802449
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
3. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
[TBL] [Abstract][Full Text] [Related]
4. X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma.
Ren Y; Wang Y; Liu J; Liu T; Yuan L; Wu C; Yang Z; Chen J
J Med Chem; 2023 May; 66(10):6697-6714. PubMed ID: 37145846
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site.
Lin S; Du T; Zhang J; Wu D; Tian H; Zhang K; Jiang L; Lu D; Sheng L; Li Y; Ji M; Chen X; Xu H
J Med Chem; 2022 Dec; 65(24):16372-16391. PubMed ID: 36511661
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
[TBL] [Abstract][Full Text] [Related]
7. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel
Leng J; Zhao Y; Sheng P; Xia Y; Chen T; Zhao S; Xie S; Yan X; Wang X; Yin Y; Kong L
J Med Chem; 2022 Dec; 65(24):16774-16800. PubMed ID: 36471625
[TBL] [Abstract][Full Text] [Related]
9. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents.
Tian C; Chen X; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2019 Dec; 183():111679. PubMed ID: 31541870
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents.
Chen H; Deng S; Albadari N; Yun MK; Zhang S; Li Y; Ma D; Parke DN; Yang L; Seagroves TN; White SW; Miller DD; Li W
J Med Chem; 2021 Aug; 64(16):12049-12074. PubMed ID: 34378386
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into SSE15206 in complex with tubulin provides a rational design for pyrazolinethioamides as tubulin polymerization inhibitors.
Ma L; Lei J; Chen H; Huang R; Su T; Feng J; Sun Q
Future Med Chem; 2022 Jun; 14(11):785-794. PubMed ID: 35506429
[No Abstract] [Full Text] [Related]
13. Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities.
Komuraiah B; Ren Y; Xue M; Cheng B; Liu J; Liu Y; Chen J
Chem Biol Drug Des; 2021 May; 97(5):1109-1116. PubMed ID: 33638903
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors.
Liu R; Zhang S; Huang M; Guo Z; Li L; Li M; Wu L; Guan Q; Zhang W
Bioorg Chem; 2021 Oct; 115():105220. PubMed ID: 34352709
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and discovery of water-soluble microtubule targeting agents that bind to the colchicine site on tubulin and circumvent Pgp mediated resistance.
Gangjee A; Zhao Y; Lin L; Raghavan S; Roberts EG; Risinger AL; Hamel E; Mooberry SL
J Med Chem; 2010 Nov; 53(22):8116-28. PubMed ID: 20973488
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities.
Ren Y; Wang Y; Li G; Zhang Z; Ma L; Cheng B; Chen J
J Med Chem; 2021 Apr; 64(8):4498-4515. PubMed ID: 33788562
[TBL] [Abstract][Full Text] [Related]
19. Tubulin Inhibitors Binding to Colchicine-Site: A Review from 2015 to 2019.
Xia LY; Zhang YL; Yang R; Wang ZC; Lu YD; Wang BZ; Zhu HL
Curr Med Chem; 2020; 27(40):6787-6814. PubMed ID: 31580244
[TBL] [Abstract][Full Text] [Related]
20. Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities.
Yang F; Yu LZ; Diao PC; Jian XE; Zhou MF; Jiang CS; You WW; Ma WF; Zhao PL
Bioorg Chem; 2019 Nov; 92():103260. PubMed ID: 31525523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
